跳至主要内容
临床试验/EUCTR2004-003906-81-LT
EUCTR2004-003906-81-LT进行中(未招募)不适用

Chemoradiation with once weekly gemcitabine for invasive bladder cancer

Oncology Institute of Vilnius University0 个研究点开始时间: 2004年10月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with clinical stage T2 - T4, N0 - N1, M0 transitional cell bladder cancer without hydronephrosis after transurethral resection, ECOG<= 2, age>18 y and <80 y, kreatinine clearance >65 ml/min, without cystostomy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with non invasive ormetastatic transitional cell bladder cancer, ECOG>2, age>80 and <18 y, cystostomy, mental disorders, graviditas.

研究者

发起方
Oncology Institute of Vilnius University

相似试验